• Idoxuridine Applications: Protocols and Troubleshooting in A

  2026-07-27

  Idoxuridine (5-iodo-2'-deoxyuridine) is a gold-standard tool for dissecting viral DNA synthesis inhibition, with proven performance in herpes simplex virus research and advanced antiviral studies. This guide details experimental workflows, troubleshooting strategies, and cross-study insights that maximize reproducibility and impact for research use only.

• Oridonin Inhibits Esophageal Cancer via TLR4/NF-κB/NLRP3 Pat

  2026-07-26

  Peng et al. (2025) demonstrate that oridonin suppresses esophageal cancer progression by targeting the TLR4/NF-κB/NLRP3 inflammasome axis in a murine model. This mechanistic insight bridges chronic inflammation and tumorigenesis, offering a framework for anti-inflammatory strategies in esophageal cancer research.

• Latrunculin A: Applied Workflows for Reversible Actin Assemb

  2026-07-25

  Latrunculin A stands out as a precision tool for dissecting actin cytoskeleton dynamics in cell biology and neuroregeneration research. Its rapid, reversible inhibition profile enables both acute and long-term experimental modulation, empowering reproducible studies of cell morphology, motility, and cytoskeleton-linked signaling.

• Cl-Amidine trifluoroacetate salt: PAD4 Inhibition in Disease

  2026-07-24

  Cl-Amidine (trifluoroacetate salt) delivers potent, selective PAD4 inhibition for robust experimental control in cancer, rheumatoid arthritis, and septic shock models. This guide translates cutting-edge AML research into actionable assay workflows and troubleshooting strategies, with deep dives into protocol enhancements and advanced applications.

• hiPSC-Derived Intestinal Organoids Advance CYP2C19 Substrate

  2026-07-24

  This study introduces a streamlined protocol for generating human induced pluripotent stem cell (hiPSC)-derived intestinal organoids optimized for pharmacokinetic and drug metabolism assays. The approach offers improved physiological relevance over traditional models, enabling more accurate evaluation of CYP2C19 substrates and supporting translational research in drug metabolism.

• HOXC8 Suppresses Pyroptosis in NSCLC via Caspase-1 Regulatio

  2026-07-23

  This study uncovers how HOXC8, a transcription factor, prevents pyroptotic cell death in non-small cell lung carcinoma (NSCLC) by suppressing caspase-1 expression. The findings clarify a novel mechanism in lung tumorigenesis, with implications for targeting cell death pathways in cancer research.

• ddATP (2',3'-dideoxyadenosine triphosphate): Driving Precisi

  2026-07-23

  Explore ddATP (2',3'-dideoxyadenosine triphosphate) as a pivotal tool for dissecting DNA damage amplification and repair mechanisms. This article uniquely bridges molecular details with assay optimization, offering advanced insight for researchers seeking to leverage ddATP in next-generation genomic studies.

• WY-14643 (Pirinixic Acid): Applied Workflows in Metabolic Re

  2026-07-22

  WY-14643 (Pirinixic Acid) stands out as a robust tool for dissecting PPARα-driven metabolic and inflammatory pathways, offering reproducible controls in both cellular and animal models. This article translates multiomics insights and recent workflow advances into actionable protocols, troubleshooting guidance, and next-generation applications for metabolic disorder research.

• Berberine and Evodiamine Modulate GERD via TAS2R38/TRPV1 Pat

  2026-07-22

  This study reveals that berberine and evodiamine synergistically alleviate gastroesophageal reflux disease (GERD) by targeting bitter taste receptor TAS2R38 and TRPV1, regulating MAPK/NF-κB signaling, and affecting macrophage polarization. The findings highlight new molecular targets for GERD intervention and provide mechanistic insights into the anti-inflammatory effects of these bioactive compounds.

• Ro 3306 (SKU A8885): Reliable CDK1 Inhibitor for G2/M Contro

  2026-07-21

  This article addresses real-world laboratory challenges in cell cycle synchronization and DNA repair research, illustrating how Ro 3306 (SKU A8885) achieves precise, reproducible G2/M phase arrest. Scenario-driven Q&A blocks offer data-backed insights for protocol optimization, assay compatibility, and vendor reliability, supporting biomedical researchers in selecting Ro 3306 as a validated, trustworthy CDK1 inhibitor.

• KPT330 Enhances CRISPR-Cas9 Precision via mRNA Nuclear Expor

  2026-07-21

  The reference study demonstrates that KPT330, a selective inhibitor of nuclear export (SINE), improves the specificity of CRISPR-Cas9 genome and base editing by indirectly modulating the nuclear export of Cas9 mRNA rather than directly inhibiting Cas9 protein. This finding introduces a novel strategy for reducing off-target effects in genome editing workflows and broadens the molecular toolbox for precision genome engineering.

• Polybrene: Mechanistic Leverage for Next-Gen Gene Delivery

  2026-07-20

  This article explores how Polybrene (Hexadimethrine Bromide) 10 mg/mL from APExBIO redefines precision gene delivery in translational research. Integrating new mitochondrial metabolism insights, it provides actionable guidance on leveraging Polybrene for viral transduction and advanced DNA transfection, while critically evaluating its mechanistic basis, protocol optimization, and clinical translation.

• Live-Dead Cell Staining Kit I: Optimizing Mammalian Cell Ass

  2026-07-20

  Harness the Live-Dead Cell Staining Kit I (Calcein AM/PI) to streamline viability and cytotoxicity workflows for mammalian cell research. Discover protocol refinements, troubleshooting strategies, and how recent breakthroughs in cancer research translate to robust, reproducible live/dead cell detection.

• Hydroxychloroquine Sulfate: Technical Use in Autoimmune Dise

  2026-07-19

  Hydroxychloroquine Sulfate (SKU B4874) is a quinoline-based inhibitor optimized for modulating autophagy and toll-like receptor (TLR7/9) signaling in autoimmune disease research workflows, particularly those modeling systemic lupus erythematosus and rheumatoid arthritis. It is specifically suited to aqueous-based, short-term protocols and should not be used in procedures requiring organic solvent solubility or long-term storage of stock solutions.

• Gap19: Selective Connexin 43 Hemichannel Blocker in Neuropro

  2026-07-18

  Gap19, a highly selective connexin 43 hemichannel blocker, empowers researchers to dissect neuroglial and immune signaling with unmatched precision. Its unique mechanism and robust solubility enable advanced studies in neuroprotection, macrophage polarization, and ischemia models.

451 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page